via Mayo Clinic
Mayo Clinic researchers have uncovered stem cell-activated mechanisms of healing after a heart attack. Stem cells restored cardiac muscle back to its condition before the heart attack, in turn providing a blueprint of how stem cells may work.
The study, published in NPJ Regenerative Medicine, finds that human cardiopoietic cells zero in on damaged proteins to reverse complex changes caused by a heart attack. Cardiopoietic cells are derived from adult stem cell sources of bone marrow.
“The extent of change caused by a heart attack is too great for the heart to repair itself or to prevent further damage from occurring. Notably, however, cardiopoietic stem cell therapy reversed, either fully or partially, two-thirds of these disease-induced changes, such that 85% of all cellular functional categories affected by disease responded favorably to treatment,” says Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine. Dr. Terzic is the senior author of the study.
This new understanding of how stem cells restore heart health could provide the framework for broader applications of stem cell therapy across various conditions.
“The actual mode of action of stem cells in repairing a diseased organ has until now been poorly understood, limiting adoption in clinical care. This study sheds light on the most intimate, yet comprehensive, regenerative mechanisms ? paving a road map for responsible and increasingly informed stem cell application,” says Dr. Terzic.
Heart disease is a leading cause of death in the U.S. Every 40 seconds, someone in the U.S. has a heart attack, according to the Centers for Disease Control and Prevention. During a heart attack, cardiac tissue dies, weakening the heart.
“The response of the diseased heart to cardiopoietic stem cell treatment revealed development and growth of new blood vessels, along with new heart tissue,” adds Kent Arrell, Ph.D., a Mayo Clinic cardiovascular researcher and first author of the study.
Researchers compared the diseased hearts of mice that did not receive human cardiopoietic stem cell therapy with those that did. Using a data science approach to map all the proteins in the heart muscle, researchers identified 4,000 cardiac proteins, more than 10% of which suffered damage by a heart attack.
“While we anticipated that the stem cell treatment would produce a beneficial outcome, we were surprised how far it shifted the state of diseased hearts away from disease and back toward a healthy, pre-disease state,” says Dr. Arrell.
Cardiopoietic stem cells are being tested in advanced clinical trials in heart patients.
“The current findings will enrich the base of knowledge pertinent to stem cell therapies and may have the potential to guide therapeutic regimens in the future,” says Dr. Terzic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Stem cell therapies
- NDA Partners Expert Consultant Ellen Areman, Receives AABB Award for Major Contributions to the Field of Cellular Therapieson October 7, 2020 at 12:00 am
NDA Partners Chief Executive Officer Earle Martin announced today that Ellen Areman, one of the firm's prominent Expert Consultants, was recently honored by AABB, formerly ...
- Okayama University research: Innovative method for determining carcinogenicity of chemicals using iPS cellson October 6, 2020 at 9:49 pm
In a recent study published in Scientific Reports researchers at Okayama University use stem cell models to show how certain chemical ...
- The Global Stem Cell Therapy Market Growth To 2023 Will Be Driven By Increasing Prevalence Of Chronic Diseaseson October 6, 2020 at 8:38 pm
"Global Stem Cell Therapy Market, Forecast Market Size, 2019 – 2023, $ Billion" The Business Research Company’s Global Stem Cell Therapy Market Report 2020-30: Covid 19 Growth And Change; Segments ...
- Cell Therapy Market and Technology Forecast, 2028 - ResearchAndMarkets.comon October 6, 2020 at 9:12 am
Market and Technology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global revenue of the cell therapy market is estimated to be around USD 6 billion in the year ...
- Biomarin snags stem cell pioneer Kevin Eggan to lead early R&Don October 5, 2020 at 8:25 am
Nearly two months after the FDA nixed its hemophilia gene therapy, BioMarin has a new early research chief. Kevin Eggan, Ph.D., a Harvard University professor and recipient of a MacArthur “genius” ...
Go deeper with Google Headlines on:
Stem cell therapies
Go deeper with Bing News on:
Stem cells repair heart damage
- Stem Cells in Cardiac Repairon October 2, 2020 at 5:00 pm
Although the heart has some ability to regenerate ... must be addressed and resolved to advance the use of stem cells in cardiac repair including identifying the optimal stem cell(s) that permit ...
- Cynata stem cells test positive for heart attack repairon September 27, 2020 at 9:30 am
ASX-listed Cynata Therapeutics, a Melbourne-based, clinical-stage biotech company specialising in cell therapeutics, has produced trial results confirming the initial success of its Cymerus ...
- Stem cells can repair Parkinson's-damaged circuits in mouse brainson September 25, 2020 at 5:00 pm
University of Wisconsin-Madison. (2020, September 26). Stem cells can repair Parkinson's-damaged circuits in mouse brains. ScienceDaily. Retrieved October 3, 2020 from www.sciencedaily.com ...
- Seaweed capsule packed with stem cells could repair damage after heart attack, scientists findon September 14, 2020 at 3:04 pm
Roughly the thickness of a grain of rice, the seaweed capsule is injected into the heart through an incision in the side of the chest. The capsules were developed by scientists in Houston, Texas.
- China Focus: Chinese study finds way to better repair injured heart muscleon September 14, 2020 at 12:14 pm
Previous studies have proven that using stem cells, which have the potential to grow into a variety of heart cell types, could repair and regenerate damaged heart tissue. However, like any other ...